Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HEMO
DateTimeSourceHeadlineSymbolCompany
25/04/202412:19Alliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
25/04/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
28/03/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
29/02/202414:04Alliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
29/02/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
16/02/202411:27Alliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
16/02/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
14/02/202410:14Alliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
14/02/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
09/02/202410:00Alliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
09/02/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
02/02/202410:44Alliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
02/02/202407:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
16/01/202411:13Alliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
16/01/202407:00UK RegulatoryHemogenyx Pharmaceuticals PLC Submission of Complete Response to Clinical HoldLSE:HEMOHemogenyx Pharmaceuticals Plc
08/01/202410:56Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes process qualification runLSE:HEMOHemogenyx Pharmaceuticals Plc
08/01/202407:00UK RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Qualification Run CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
28/11/202316:53Alliance NewsAlliance NewsTRADING UPDATES: Upland Resources completes technical study at SarawakLSE:HEMOHemogenyx Pharmaceuticals Plc
28/11/202312:19UK RegulatoryHemogenyx Pharmaceuticals PLC Placing to Raise GBP534,375LSE:HEMOHemogenyx Pharmaceuticals Plc
27/11/202310:52Alliance NewsAlliance NewsHemogenyx shares up as says CBR platform a potential cancer treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
27/11/202307:00UK RegulatoryHemogenyx Pharmaceuticals PLC CBR Expanded to Treatment of CancerLSE:HEMOHemogenyx Pharmaceuticals Plc
15/11/202315:43Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes lentivirus re-manufactureLSE:HEMOHemogenyx Pharmaceuticals Plc
15/11/202307:00UK RegulatoryHemogenyx Pharmaceuticals PLC Lentivirus Re-manufacturing CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
31/10/202307:00UK RegulatoryHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
28/09/202314:24Alliance NewsAlliance NewsEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensLSE:HEMOHemogenyx Pharmaceuticals Plc
28/09/202312:28UK RegulatoryHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
18/09/202314:37Alliance NewsAlliance NewsTRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells QuestersLSE:HEMOHemogenyx Pharmaceuticals Plc
18/09/202307:00UK RegulatoryHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
14/09/202314:31Alliance NewsAlliance NewsHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift planLSE:HEMOHemogenyx Pharmaceuticals Plc
14/09/202309:11Dow Jones NewsHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsLSE:HEMOHemogenyx Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HEMO